ARCHIVES

FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview.

This article is from The Cancer Letter archive.

Vol. 29 No. 41 | November 7, 2003

Download PDF Visit The Full Archive

Related Articles

Also in this 8-page issue: Dana-Farber opens center for advanced cancer science.

April 23, 2004

Cytopathologists, NCI Recommend New Method For Pap Smear Reports

August 25, 1989

U.S., France Offer Carcinogenesis Program

February 13, 1981

FDA Announces Plan to Reform Drug Approval, Hire Outside Experts To Handel Some Reviews

November 22, 1991

Society Recognizes Community Oncologists (8-page issue).

June 6, 2003

Tobacco Linked To 63 Percent Of Cancer Deaths In Black Men

July 29, 2005